The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Next-Generation In Vitro Diagnostics (IVD) Market Over The 2026–2030 Period?
The next-generation in vitro diagnostics (ivd) market size has seen rapid expansion in recent years. It is projected to grow from $117.97 billion in 2025 to $129.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.1%. Historically, this growth has been fueled by factors such as the increasing prevalence of infectious diseases, the rising burden of chronic diseases, greater adoption of molecular diagnostics, the expansion of clinical laboratory infrastructure, and government funding for diagnostic programs.
The market size for next-generation in vitro diagnostics (IVD) is anticipated to experience substantial growth in the coming years. It is projected to expand to $188.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected increase can be attributed to factors such as a growing demand for precision medicine, the expansion of genomic testing applications, increasing adoption of point-of-care diagnostics, rising healthcare digitization, and enhanced investments in diagnostic research and development. Significant trends expected during this forecast period include a shift towards personalized and companion diagnostics, the rapid embrace of point-of-care and decentralized testing, the integration of multiplex and high-throughput assays, an escalating demand for early disease detection and screening, and the development of non-invasive and liquid biopsy diagnostics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25848&type=smp
Which Major Factors Are Driving The Expansion Of The Next-Generation In Vitro Diagnostics (IVD) Market?
The burgeoning requirement for personalized medicine is anticipated to accelerate the expansion of the next-generation in vitro diagnostics (IVD) market in the future. Precision medicine, defined as a healthcare strategy, tailors disease prevention and therapy according to an individual’s genetic characteristics, surroundings, and way of life. The growth of personalized medicine stems from the increasing availability of genomic information, empowering healthcare practitioners to develop targeted therapies aligned with a person’s distinct genetic makeup, resulting in enhanced treatment outcomes. Next-generation in vitro diagnostics (IVD) plays a crucial role in personalized medicine by furnishing accurate molecular and genetic understandings, which facilitate customized treatment and preventative approaches for individual patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that in 2023, the FDA sanctioned 16 novel personalized treatments for patients with rare diseases, a significant increase from six in 2022. Consequently, the escalating demand for personalized medicine is fueling the growth of the next-generation in vitro diagnostics (IVD) market.
How Is The Next-Generation In Vitro Diagnostics (IVD) Market Segmented Across Key Categories?
The next-generation in vitro diagnostics (ivd) market covered in this report is segmented –
1) By Product Type: Consumables, Instruments, Software
2) By Diagnostic Modality: Core Laboratory Diagnostics, Point-Of-Care Testing, Molecular Diagnostics
3) By Application: Oncology Or Cancer, Infectious Diseases, Diabetes, Cardiology , Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users
Subsegments:
1) By Consumables: Assay Kits And Reagents, Specimen Bags and Tubes, Seals and Caps
2) By Instruments: Automated Sample Preparation Systems, High-Throughput Molecular Diagnostic Analyzers, Next-Generation Sequencing Platforms, Integrated Diagnostic Workstations And Analysis Platforms, Digital PCR Systems And Advanced Real-Time PCR Instruments
3) By Software: Laboratory Information Management Systems, Specimen Tracking Software Modules, Cloud-Based Tracking Software
Which Upcoming Trends Are Expected To Influence The Next-Generation In Vitro Diagnostics (IVD) Market?
Major companies operating in the next-generation in vitro diagnostics (IVD) market are embracing a strategic partnerships approach. This method in next-generation in vitro diagnostics involves working together with technology providers, research institutions, and healthcare organizations to accelerate innovation, improve diagnostic accuracy, and expand access to advanced testing solutions for individuals, businesses, and governments. Strategic partnerships represent a process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. For example, in October 2024, Yourgene Health, a UK-based biotechnology company, collaborated with Genetix, a Colombia-based human genetic diagnosis company, to launch Colombia’s first local non-invasive prenatal testing (NIPT) service. This initiative marks a substantial advancement in prenatal care within the region, offering expectant parents quicker, more reliable, and cost-effective access to sophisticated genetic screening. The service utilizes Yourgene Health’s IONA Nx NIPT Workflow, which is a comprehensive, CE-marked in vitro diagnostic (IVD) solution. This workflow demonstrates high flexibility and scalability, making it suitable for varying sample volumes, and allows Genetix to provide a quality-assured prenatal screening service within Colombia.
Who Are The Dominant Players Shaping The Next-Generation In Vitro Diagnostics (IVD) Market Landscape?
Major companies operating in the next-generation in vitro diagnostics (ivd) market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc, Seegene Inc, BGI Genomics Co Ltd, Oxford Nanopore Technologies plc
Read the full next-generation in vitro diagnostics (ivd) market report here:
Which Region Currently Holds The Largest Share Of The Next-Generation In Vitro Diagnostics (IVD) Market?
North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Next-Generation In Vitro Diagnostics (IVD) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25848&type=smp
Browse Through More Reports Similar to the Global Next-Generation In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company
In Vitro Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
In Vitro Diagnostic Ivd In Cardiology And Neurology Market Report 2026
Bioinformatics In In Vitro Diagnostics Ivd Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model